Annual Operating Expenses
$301.45 M
-$96.39 M-24.23%
December 31, 2023
Summary
- As of February 7, 2025, CHRS annual total operating expenses is $301.45 million, with the most recent change of -$96.39 million (-24.23%) on December 31, 2023.
- During the last 3 years, CHRS annual operating expenses has risen by +$19.61 million (+6.96%).
- CHRS annual operating expenses is now -43.42% below its all-time high of $532.82 million, reached on December 31, 2021.
Performance
CHRS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$56.42 M
-$700.00 K-1.23%
September 30, 2024
Summary
- As of February 7, 2025, CHRS quarterly total operating expenses is $56.42 million, with the most recent change of -$700.00 thousand (-1.23%) on September 30, 2024.
- Over the past year, CHRS quarterly operating expenses has dropped by -$17.45 million (-23.62%).
- CHRS quarterly operating expenses is now -76.77% below its all-time high of $242.88 million, reached on March 31, 2021.
Performance
CHRS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CHRS Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -24.2% | -23.6% |
3 y3 years | +7.0% | -17.5% |
5 y5 years | +47.5% | -17.5% |
CHRS Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -43.4% | at low | -57.1% | at low |
5 y | 5-year | -43.4% | +30.4% | -76.8% | at low |
alltime | all time | -43.4% | +678.1% | -76.8% | +674.0% |
Coherus BioSciences Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $56.42 M(-1.2%) |
Jun 2024 | - | $57.12 M(-32.8%) |
Mar 2024 | - | $85.00 M(+12.0%) |
Dec 2023 | $301.45 M(-24.2%) | $75.86 M(+2.7%) |
Sep 2023 | - | $73.87 M(+8.0%) |
Jun 2023 | - | $68.41 M(-17.9%) |
Mar 2023 | - | $83.31 M(+0.8%) |
Dec 2022 | $397.84 M(-25.3%) | $82.64 M(-8.8%) |
Sep 2022 | - | $90.64 M(-2.4%) |
Jun 2022 | - | $92.89 M(-29.5%) |
Mar 2022 | - | $131.67 M(+30.6%) |
Dec 2021 | $532.82 M(+89.1%) | $100.81 M(+7.2%) |
Sep 2021 | - | $94.01 M(-1.2%) |
Jun 2021 | - | $95.11 M(-60.8%) |
Mar 2021 | - | $242.88 M(+195.0%) |
Dec 2020 | $281.84 M(+21.9%) | $82.32 M(+16.2%) |
Sep 2020 | - | $70.83 M(+17.6%) |
Jun 2020 | - | $60.23 M(-12.0%) |
Mar 2020 | - | $68.46 M(-3.6%) |
Dec 2019 | $231.22 M(+13.1%) | $71.02 M(+33.0%) |
Sep 2019 | - | $53.40 M(-3.5%) |
Jun 2019 | - | $55.34 M(+7.5%) |
Mar 2019 | - | $51.47 M(-14.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $204.42 M(-12.5%) | $60.50 M(+6.2%) |
Sep 2018 | - | $56.97 M(+26.9%) |
Jun 2018 | - | $44.91 M(+6.8%) |
Mar 2018 | - | $42.03 M(-9.5%) |
Dec 2017 | $233.69 M(-23.6%) | $46.47 M(-17.9%) |
Sep 2017 | - | $56.62 M(-2.4%) |
Jun 2017 | - | $58.03 M(-20.0%) |
Mar 2017 | - | $72.58 M(-2.3%) |
Dec 2016 | $306.04 M(+22.9%) | $74.30 M(-5.0%) |
Sep 2016 | - | $78.22 M(+1.8%) |
Jun 2016 | - | $76.80 M(+0.1%) |
Mar 2016 | - | $76.71 M(+22.9%) |
Dec 2015 | $249.11 M(+160.1%) | $62.41 M(-20.4%) |
Sep 2015 | - | $78.38 M(+19.2%) |
Jun 2015 | - | $65.76 M(+54.5%) |
Mar 2015 | - | $42.56 M(+28.8%) |
Dec 2014 | $95.79 M(+147.2%) | $33.05 M(+47.1%) |
Sep 2014 | - | $22.48 M(-1.9%) |
Jun 2014 | - | $22.90 M(+32.0%) |
Mar 2014 | - | $17.36 M(+48.1%) |
Dec 2013 | $38.74 M(-4.1%) | $11.72 M(+60.8%) |
Sep 2013 | - | $7.29 M |
Dec 2012 | $40.42 M | - |
FAQ
- What is Coherus BioSciences annual total operating expenses?
- What is the all time high annual operating expenses for Coherus BioSciences?
- What is Coherus BioSciences annual operating expenses year-on-year change?
- What is Coherus BioSciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Coherus BioSciences?
- What is Coherus BioSciences quarterly operating expenses year-on-year change?
What is Coherus BioSciences annual total operating expenses?
The current annual operating expenses of CHRS is $301.45 M
What is the all time high annual operating expenses for Coherus BioSciences?
Coherus BioSciences all-time high annual total operating expenses is $532.82 M
What is Coherus BioSciences annual operating expenses year-on-year change?
Over the past year, CHRS annual total operating expenses has changed by -$96.39 M (-24.23%)
What is Coherus BioSciences quarterly total operating expenses?
The current quarterly operating expenses of CHRS is $56.42 M
What is the all time high quarterly operating expenses for Coherus BioSciences?
Coherus BioSciences all-time high quarterly total operating expenses is $242.88 M
What is Coherus BioSciences quarterly operating expenses year-on-year change?
Over the past year, CHRS quarterly total operating expenses has changed by -$17.45 M (-23.62%)